Right Embryo
Advancing Standards of Care with our four-in-one genetic test
PGT-Complete is our most comprehensive PGT-A test
The PGT-Complete test provides our most comprehensive screening of your embryos, allowing you and your physician to make fully-informed embryo transfer decisions.
PGT-A
All the benefits of our innovative PGTai® 2.0 to improve the chances of IVF success
Parental QC*
Provides patients reassurance that the intended egg and sperm were used, to help reduce parental anxiety of potential mix-ups
Genetic PN check
Gives the capability to identify and rescue true 2PN embryos from morphologically identified 0, 1, and 3PN embryos, to confidently enable additional euploid embryo transfers
Origin of aneuploidy
Supports the clinic and patient, by identifying the origin of abnormality, to guide future decisions
Watch our PGT-Complete Webinar
” Keep up this great work!
It is especially impressive with the amount of data you have. It gives great confidence to clinicians and ultimately our patients! “
Karen Sage, MSc, GC, Co-Founder, Fertility Genetics
How is our PGT-A test different?
CooperSurgical® uses artificial intelligence (PGTai® Platform) to analyze your embryo data
How our test works
Our artificial intelligence platform is based on thousands of embryos that resulted in healthy live births. This means the chromosomal status of your embryo is checked against the data taken from these embryos, improving the accuracy of our test.
How PGTai® Platform benefits you compared to other PGT-A technology
- Has been shown to increase ongoing pregnancy and live birth rates2
- Biochemical pregnancy loss rates and spontaneous abortion reduced2
- More euploid embryos available for transfer4
Parental QC*
Reassuring you by confirming the correct egg and sperm have been used
Today’s IVF patient is more educated, motivated, and involved in their treatment than ever before. The Parental QC test feature confirms a match** between the embryo biopsy sample and the provided patient samples through DNA fingerprinting. DNA fingerprinting allows us to match each sample to a unique individual. This reduces the anxiety of potential mix-ups.
* Parental QC is not reported in countries where it is not permitted by regulatory bodies.
**A match is defined as a genetic analysis that is consistent with a shared inheritance and familial relationship between the parental samples and the embryo biopsy sample
Genetic PN check
Empowering additional embryo transfers
Empowering your clinical team with additional embryos for transfer with Genetic PN (pronuclear) checking, you can feel confident that all available euploid embryos are given every opportunity to be genetically tested, increasing transfer potential. Moreover, if you have a history of triploid loss or a partial/molar pregnancy, Genetic PN checking may help to avoid these challenges on your next transfer.
Origin of aneuploidy
Empowering your patients
The origin of aneuploidy feature included in our PGT-Complete analysis provides a direct assessment of gametic contribution to embryo aneuploidy, helping your patient make informed donor gamete decisions.
For patients considering donor gametes it is important to understand that not all aneuploidy is maternally derived, as often paternal contribution to aneuploidy can be overlooked.
Simple test process
Designed with the patient in mind every step of the way
At CooperSurgical, we recognize that each sample that comes through our laboratory belongs to an individual or family with their own unique story and journey. We take a personalized approach to patient care and clinical service.
PGT-Complete selected on test requistion form
Embryo biopsy and parental cheek (buccal) swabs collected & shipped to CooperGenomics
Samples analyzed and reported back to the clinic
Genetic testing consultation is available before or after testing
References
1. JBRA Assist Reprod. 2020 Apr-Jun; 24(2): 143–146. Blastocysts Derived From 0PN Oocytes: Genetic And Clinical Results
2. Buldo-Licciardi J, Large M, McCulloh D, McCaffrey C, Grifo J. Second generation artificial intelligence technology for preimplantation genetic testing (PRT) improves pregnancy outcomes in single thawed euploid embryo transfer cycles (STEET).
Presented at American Society for Reproductive Medicine on October 19, 2020. Available at: https://asrm.confex.com/asrm/2020/meetingapp.cgi/Paper/8645. Accessed Feb 18, 2022.
3. CooperGenomics, internal data on file.